2024-519109-36-00招募中4 期
Bioequivalence of Canagliflozin 300 mg Film-Coated Tablets in Healthy Participants Under Fasting Conditions.
Tecnimede-Sociedade Tecnico-Medicinal S.A.1 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2025年6月24日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 58
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Rita Neves
Scientific
Tecnimede-Sociedade Tecnico-Medicinal S.A.
研究点 (1)
Loading locations...
相似试验
已完成
4 期
A clinical trial to compare the effects of Canagliflozin and Sitagliptin in Patients with Type 2 Diabetes mellitus on a background metformin therapy.CTRI/2019/02/017435SRM College of Pharmacy40
招募中
不适用
The efficacy and safety of Canagliflozin for the treatment of NAFLD/NASH patients with type2 DMAFLD/NASHJPRN-UMIN000036560ippon Medical School Chiba Hokusoh Hospital Division of Gastroenterology30
尚未招募
不适用
Effect of canagliflozin as an alternative drug from DPP-4 inhibitor on heart failure with diabetis melltus : the pilot study "Can canagliflozin HAve Not only hypoGlycemic but cardiac supportive Effect?"chronic heart failure with type 2 diabetis mellitusJPRN-UMIN000031563Osaka Rosai Hospital40
进行中（未招募）
1 期
The effect of canagliflozin 300mg on glucose levels in people without diabetes after weight loss surgery.EUCTR2019-004041-32-GBniversity of Leicester24
已完成
不适用
Efficacy of canagliflozin versus liraglutide, alternative to bolus insulin in patients with basal-bolus regimen.Type 2 diabetes mellitusJPRN-UMIN000019382Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Toho University School of Medicine40